The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Ionotropic Glutamate Receptors and Expression of N-Methyl-d-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia
Abstract
OBJECTIVE: Multiple quantifiable biologic abnormalities have been localized to the hippocampus in schizophrenia. Alterations in glutamate-mediated transmission at N-methyl-D-aspartic acid (NMDA)-sensitive receptors in hippocampus have been implicated in the pathophysiology of the illness. The authors tested the hypothesis that glutamatergic transmission within and efferent from hippocampus is altered in schizophrenia. METHOD: The authors analyzed postmortem hippocampal tissue from individuals with schizophrenia and from healthy individuals. The tissue samples had been collected by two brain tissue banks, one in Maryland and the other in Melbourne, Australia. lonotropic receptor binding for the NMDA, kainate, and (3)H-amino-3-hydroxy-5-methylisoxazol-4-propionate (AMPA) receptors was quantified by using usual radioligand techniques. In situ hybridization autoradiography was used to quantify mRNA for the NMDA receptor subunits NR1, NR2A, and NR2B. RESULTS: Ligand binding to the ionotropic glutamate receptors (NMDA, kainate, and AMPA) did not differ significantly overall or in any subregion between the schizophrenia tissue and the healthy comparison tissue. The only exception was AMPA receptor binding in hippocampal subregion CA2, which was slightly but significantly less in schizophrenia. However, the level of mRNA for the NMDA receptor subunits NR1 and NR2B was significantly different between groups; in several hippocampal subregions, the level of NR1 mRNA was lower and the level of NR2B mRNA higher in schizophrenia. CONCLUSIONS: Because the NR1 subunit of the NMDA receptor is critical to full receptor activity, a reduction of NR1 in hippocampus in schizophrenia suggests a functional impairment in glutamatergic transmission at the NMDA receptor, resulting in reduced glutamatergic transmission within and possibly efferent from the hippocampus in schizophrenia. This defect could underlie a hypoglutamatergic state in regions of limbic cortex, consistent with published results from other lines of research in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain
Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81826-7 · Cited by 1,280
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921
Wolosker, H., Blackshaw, S., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13409 · Cited by 811
Stevens, J. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200020023003 · Cited by 722
Impaired Hippocampal Representation of Space in CA1-Specific NMDAR1 Knockout Mice
McHugh, T. J., Blum, K. I., Tsien, J. Z., Tonegawa, S., & Wilson, M. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81828-0 · Cited by 593
A neurohistological correlate of schizophrenia.
Kovelman, J. A., & Scheibel, A. B. (1984) · PubMed · Cited by 582
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
Heckers, S., Rauch, S., Goff, D., Savage, C., Schacter, D., Fischman, A., & Alpert, N. (1998) · Nature Neuroscience · doi:10.1038/1137 · Cited by 570
Tamminga, C. A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070016003 · Cited by 547
Self-citationBogerts, B., Ashtari, M., Degreef, G., Alvir, J. M. J., Bilder, R. M., & Lieberman, J. A. (1990) · Psychiatry Research: Neuroimaging · doi:10.1016/0925-4927(90)90004-p · Cited by 544
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
Heckers, S., Rauch, S. L., Goff, D., Savage, C. R., Schacter, D. L., Fischman, A. J., & Alpert, N. M. (1998) · NeuroImage · doi:10.1016/s1053-8119(18)30930-3 · Cited by 492
Cell loss in the hippocampus of schizophrenics
Falkai, P., & Bogerts, B. (1986) · European Archives of Psychiatry and Neurological Sciences · doi:10.1007/bf00380943 · Cited by 489
Hippocampal morphometry in schizophrenia by high dimensional brain mapping
Csernansky, J. G., Joshi, S., Wang, L., Haller, J. W., Gado, M., Miller, J. P., Grenander, U., & Miller, M. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11406 · Cited by 470
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Abnormal Excitatory Neurotransmitter Metabolism in Schizophrenic Brains
Tsai, G. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220039008 · Cited by 455
Hippocampal Pathologic Findings in Schizophrenia: A Morphometric Study
Jeste, D. V. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110061009 · Cited by 429
Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.4.464 · Cited by 419
Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia
Deakin, J. F. W., Slater, P., Simpson, M. D. C., Gilchrist, A. C., Skan, W. J., Royston, M. C., Reynolds, G. P., & Cross, A. J. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07257.x · Cited by 386
Schizophrenia and Glutamatergic Transmission
Tamminga, C. A. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.20 · Cited by 385
Self-citationGruzelier, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800310027003 · Cited by 363
Tissue pH as an indicator of mRNA preservation in human post-mortem brain
Kingsbury, A. E., Foster, O. J. F., Nisbet, A. P., Cairns, N., Bray, L., Eve, D. J., Lees, A. J., & David Marsden, C. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00219-5 · Cited by 321
Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients
Benes, F. M., Sorensen, I., & Bird, E. D. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.597 · Cited by 283
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
Kornhuber, J., Mack-Burkhardt, F., Riederer, P., Hebenstreit, G. F., Reynolds, G. P., Andrews, H. B., & Beckmann, H. (1989) · Journal of Neural Transmission · doi:10.1007/bf01248936 · Cited by 250
Kerwin, R., Patel, S., & Meldrum, B. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90219-t · Cited by 239
Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
Harrison, P. J., McLaughlin, D., & Kerwin, R. W. (1991) · The Lancet · doi:10.1016/0140-6736(91)93392-m · Cited by 238
Bogerts, B., Falkai, P., Haupts, M., Greve, B., Ernst, S., Tapernon-Franz, U., & Heinzmann, U. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90013-w · Cited by 227
Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
Reynolds, G. P., Czudek, C., & Andrews, H. B. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90039-5 · Cited by 199
Eastwood, S. L., & Harrison, P. J. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00324-c · Cited by 193
Reduced GABA uptake sites in the temporal lobe in schizophrenia
Simpson, M. D. C., Slater, P., Deakin, J. F. W., Royston, M. C., & Skan, W. J. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90819-7 · Cited by 192
Hippocampal Neuron Number in Schizophrenia: A Stereological Study
Heckers, S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810350042006 · Cited by 187
The Hippocampus and Parahippocampus in Schizophrenic, Suicide, and Control Brains
Altshuler, L. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230045008 · Cited by 186
Bilder, R. M., Bogerts, B., Ashtari, M., Wu, H., Alvir, J. M., Jody, D., Reiter, G., Bell, L., & Lieberman, J. A. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00028-k · Cited by 181
ASYMMETRICAL LOSS OF GLUTAMATE RECEPTOR SUBTYPE IN LEFT HIPPOCAMPUS IN SCHIZOPHRENIA
Kerwin, R. W., Patel, S., Meldrum, B. S., Czudek, C., & Reynolds, G. P. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91371-2 · Cited by 177
Porter, R. H. P., Eastwood, S. L., & Harrison, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01404-7 · Cited by 158
Roberts, E. B., Meredith, M. A., & Ramoa, A. S. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.3.1021 · Cited by 137
Breese, C. R., Freedman, R., & Leonard, S. S. (1995) · Brain Research · doi:10.1016/0006-8993(94)01384-t · Cited by 134
Brimecombe, J. C., Boeckman, F. A., & Aizenman, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.11019 · Cited by 129
Decreased anterior cingulate gyrus metabolic rate in schizophrenia
Haznedar, M. M., Buchsbaum, M. S., Luu, C., Hazlett, E., Siegel, B. V., Lohr, J. B., Wu, J. C., Haier, R. J., & Bunney, W. E. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.5.682 · Cited by 124
Problem of diagnosis in postmortem brain studies of schizophrenia
Hill, C., Keks, N. A., Roberts, S., Opeskin, K., Dean, B., Mackinnon, A. J., & Copolov, D. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.533 · Cited by 118
Self-citationEastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00195-7 · Cited by 107
Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse.
Gd, P. (1981) · PubMed · Cited by 92
Zaidel, D. W., Esiri, M. M., & Harrison, P. J. (1997) · Psychological Medicine · doi:10.1017/s0033291796004618 · Cited by 90
NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia
Grimwood, S., Slater, P., Deakin, J. F. W., & Hutson, P. H. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00004 · Cited by 89
Becker, T. M., Elmer, K., Schneider, F. W., Schneider, M., Grodd, W., Bartels, M., Heckers, S., & Beckmann, H. (1996) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(96)03002-8 · Cited by 87
Simpson, M. D. C., Slater, P., Royston, M. C., & Deakin, J. F. W. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90119-n · Cited by 78
Gray, J. A. (1995) · Neuropsychologia · doi:10.1016/0028-3932(95)00054-7 · Cited by 78
The role of excitatory amino acids in neuropsychiatric illness
Javitt, D. C., & Zukin, S. R. (1990) · Journal of Neuropsychiatry · doi:10.1176/jnp.2.1.44 · Cited by 75
Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics
Sherman, A. D., Hegwood, T. S., Baruah, S., & Waziri, R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90155-f · Cited by 70
The missing link: a failure of fronto-hippocampal integration in schizophrenia
Fletcher, P. C. (1998) · Nature Neuroscience · doi:10.1038/1078 · Cited by 67
Delayed regional metabolic actions of phencyclidine
Gao, X.-M., Shirakawa, O., Du, F., & Tamminga, C. A. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90926-9 · Cited by 66
Self-citationHippocampal Function and Schizophrenia. Experimental Psychological Evidencea
Venables, P. H. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22841.x · Cited by 57
NORDAHL, T. E. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00098-x · Cited by 56
Opposing Contributions of NR1 and NR2 to Protein Kinase C Modulation of NMDA Receptors
Grant, E. R., Bacskai, B. J., Anegawa, N. J., Pleasure, D., & Lynch, D. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041471.x · Cited by 46
Riley, B. P., Tahir, E., Rajagopalan, S., Mogudi-Carter, M., Fauré, S., Weissenbach, J., Jenkins, T., & Williamson, R. (1997) · Psychiatric Genetics · doi:10.1097/00041444-199722000-00002 · Cited by 46
Expression of the NMDA R1 receptor in selected human brain regions
Böckers, T. M., Zimmer, M., Müller, A., Bergmann, M., Brose, N., & Kreutz, M. R. (1994) · Neuroreport · doi:10.1097/00001756-199404000-00028 · Cited by 43
NMDA-Associated glycine binding site increases in schizophrenic brains
Ishimaru, M. J., Kurumaji, A., & Toru, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90043-y · Cited by 41
Gao, X., Hashimoto, T., Cooper, T. B., & Tamminga, C. A. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271298 · Cited by 31
Self-citationGao, X.-M., & Tamminga, C. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90008-6 · Cited by 26
Self-citationMK801 induces late regional increases in NMDA and kainate receptor binding in rat brain
Gao, X. M., & Tamminga, C. A. (1995) · Journal of Neural Transmission · doi:10.1007/bf01271549 · Cited by 25
Self-citationFree amino acid level determinations in normal and schizophrenic brain
Kutay, F., Pöğün, Ş., Harirî, N. I., Peker, G., & Erlaçin, S. (1989) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(89)90008-0 · Cited by 12
Cited by
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Goff, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 915
Harrison, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1761-y · Cited by 693
Increased cortical kynurenate content in schizophrenia
Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590
Self-citationThe Hippocampal Formation in Schizophrenia
Tamminga, C. A., Stan, A. D., & Wagner, A. D. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09081187 · Cited by 582
Self-citation
Metadata
- Authors
- Gao, X.-M., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., & Tamminga, C. A.
- Venue
- American Journal of Psychiatry
- Published
- 2000-07-01
- Volume
- 157
- Issue
- 7
- Pages
- 1141-1149
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2143417330
- Cited by
- 372
- References
- 64
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.